We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

144 hedge funds and large institutions have $982M invested in TherapeuticsMD in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 20

44% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 34

13% more capital invested

Capital invested by funds: $867M → $982M (+$115M)

7% more funds holding

Funds holding: 134 → 144 (+10)

0.02% less ownership

Funds ownership: 1.52% → 1.5% (-0.02%)

63% less call options, than puts

Call options by funds: $2.71M | Put options by funds: $7.26M

Holders
144
Holders Change
+10
Holders Change %
+7.46%
% of All Funds
3.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
49
Reduced
34
Closed
20
Calls
$2.71M
Puts
$7.26M
Net Calls
-$4.55M
Net Calls Change
-$4.18M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$18.4M
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$17.2M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.98M
4
First Eagle Investment Management
First Eagle Investment Management
New York
+$8.73M
5
AAP
Ardsley Advisory Partners
Connecticut
+$5.71M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$34.1M
2
JP Morgan Chase
JP Morgan Chase
New York
-$13.3M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$12.4M
4
CCI
Columbus Circle Investors
-$10.7M
5
LCM
Laurion Capital Management
New York
-$3.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
$307K -$290K -1,043 -51%
Bank of America
77
Bank of America
North Carolina
$305K +$133K +479 +90%
PPA
78
Parametric Portfolio Associates
Washington
$302K +$97.2K +349 +54%
CA
79
Cetera Advisors
Colorado
$294K +$33.1K +119 +14%
CAN
80
Claraphi Advisory Network
United States
$275K +$253K +910 New
Tudor Investment Corp
81
Tudor Investment Corp
Connecticut
$271K -$1.33M -4,760 -84%
SB
82
Suntrust Banks
Georgia
$246K – – –
Public Employees Retirement Association of Colorado
83
Public Employees Retirement Association of Colorado
Colorado
$245K – – –
Invesco
84
Invesco
Georgia
$227K +$1.39K +5 +0.7%
BNP Paribas Financial Markets
85
BNP Paribas Financial Markets
France
$212K +$102K +366 +109%
AG
86
Aperio Group
California
$203K -$3.62K -13 -2%
Principal Financial Group
87
Principal Financial Group
Iowa
$194K +$76.3K +274 +74%
GCP
88
GSA Capital Partners
United Kingdom
$190K -$381K -1,368 -69%
UBS Group
89
UBS Group
Switzerland
$190K -$278 -1 -0.2%
LTFS
90
Ladenburg Thalmann Financial Services
Florida
$184K +$33.4K +120 +25%
FMBTD
91
First Midwest Bank Trust Division
Illinois
$168K – – –
Parallax Volatility Advisers
92
Parallax Volatility Advisers
California
$149K +$137K +492 New
TCM
93
Traynor Capital Management
Pennsylvania
$147K -$10K -36 -7%
AB
94
Amalgamated Bank
New York
$137K +$15K +54 +14%
EWM
95
Edge Wealth Management
New York
$125K +$111K +400 +2,500%
Royal Bank of Canada
96
Royal Bank of Canada
Ontario, Canada
$121K -$54.8K -197 -33%
Citigroup
97
Citigroup
New York
$121K +$92.4K +332 +503%
MAS
98
Managed Account Services
Florida
$109K -$2.78K -10 -3%
Commonwealth Equity Services
99
Commonwealth Equity Services
Massachusetts
$107K +$98.8K +355 New
GS
100
Gagnon Securities
New York
$105K – – –
2 3
4
5 6

TXMD Hedge Fund Activity: Q4 2017 in Review

144 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q4 2017, worth a combined $982M — up 13% from $867M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TXMD positions and 20 closed out — a net gain of 11 holders — while 49 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $18.4M. The largest seller was Fidelity Investments, cutting an estimated $34.1M.

  • 144 institutional investors held TherapeuticsMD (TXMD) as of Q4 2017, up from 134 in Q3 2017.
  • Funds reported $982M of TherapeuticsMD stock for Q4 2017, up 13% quarter-over-quarter.
  • 31 funds opened new TherapeuticsMD positions in Q4 2017 and 20 closed out, a net change of +11 holders.
  • The largest TherapeuticsMD buyer in Q4 2017 was BlackRock, an estimated $18.4M added.
  • The largest TherapeuticsMD seller in Q4 2017 was Fidelity Investments, an estimated $34.1M sold.

Based on aggregated 13F filings for Q4 2017.